Headline News about Esperion Theraptc![]() ![]() Via Benzinga
![]() Via Benzinga
![]()
The Latest Analyst Ratings for Esperion Therapeutics
February 27, 2023
Via Benzinga
![]()
Looking Into Esperion Therapeutics's Return On Capital Employed
February 22, 2023
Via Benzinga
![]()
Esperion Therapeutics's Earnings Outlook
February 20, 2023
Via Benzinga
![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]()
12 Health Care Stocks Moving In Monday's Intraday Session
March 06, 2023
Via Benzinga
![]() ![]() ![]() ![]()
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 06, 2023
Via Benzinga
![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
February 03, 2023
Via Benzinga
![]() ![]()
Esperion Therapeutics Reports Sooner Than Expected Positive Data From Nexletol Trial
December 07, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|